Travel Medicine Advisor Archives – November 1, 2006
November 1, 2006
View Issues
-
Clostridium difficile-Associated Diarrhea (CDAD): Novel Therapeutics
Lagrotteria and colleagues enrolled 39 in- patients with a primary episode of Clostridium difficile-associated diarrhea (CDAD) to receive treatment for 10 days with either metronidazole (MET) alone or together with rifampin (RIF). -
VZIG — No Longer Readily Available
The only manufacturer of vzig in the united States recently stopped its production. An alternate product, VariZIG, which is manufactured by a Canadian company and has not been approved for use in the United States by the FDA, can be obtained in the United States, but only through expanded access as an investigational new drug. -
Public Health Cost of Imported Measles
Parker and colleagues describe the public health effort required to contain the largest outbreak of measles occurring in the United States in the past 10 years. The outbreak, which occurred in Indiana in 2005, began when a 17-year-old girl who was incubating measles arrived from Romania. -
Pharmacology Watch: Wait and See Prescriptions for Treatment of Otitis Media
New Hope for Macular Degeneration?; Can Cialis be Used for Edema?; FDA Actions